Provided By GlobeNewswire
Last update: Sep 5, 2025
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that it has closed a non-brokered private placement (“Private placement”), initially announced on September 3, 2025, of 10 units (each a “Unit”) issued at a price of $10,000 per Unit, for gross proceeds of $100,000.
Read more at globenewswire.com